How do we treat: Upper gastrointestinal bleeding in adults with haemophilia

Haemophilia

Volumn 16, Issue 2, 2010, Pages 360-362

  Kouides, P A ^a   Fogarty, P F ^b  

^a ROCHESTER GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOCAPROIC ACID; BLOOD CLOTTING FACTOR 8; HEMOGLOBIN; IBUPROFEN; PREDNISONE;

ADULT; CASE REPORT; DISEASE SEVERITY; DUODENITIS; DUODENUM ULCER; ERYTHROCYTE; ESOPHAGOGASTRODUODENOSCOPY; GASTRITIS; HEMATEMESIS; HEMOPHILIA; HUMAN; HYPOTENSION; MALE; MYALGIA; NOTE; ORAL BLISTER; PRIORITY JOURNAL; RASH; STEVENS JOHNSON SYNDROME; UPPER GASTROINTESTINAL BLEEDING; VIRUS INFECTION;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CYCLOOXYGENASE 2 INHIBITORS; GASTROINTESTINAL HEMORRHAGE; HELICOBACTER INFECTIONS; HEMOPHILIA A; HUMANS; MALE; PAIN; UPPER GASTROINTESTINAL TRACT; YOUNG ADULT;

EID: 77950204608     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2009.02130.x     Document Type: Note

References (17)

1. Forbes CD, Barr RD, Prentice CRM, Douglas AS. Gastrointestinal bleeding in haemophilia. Q J Med 1973, 42:503-11.
2. Eyster ME, Asaad SM, Gold BD, Cohn SE, Goedert JJ. Upper gastrointestinal bleeding in haemophiliacs: incidence and relation to use of non-steroidal anti-inflammatory drugs. Haemophilia 2007, 13:279-86.
3. Lanas A, Perez-Aisa MA, Feu F. A nationwide study of mortality associated with hospital admission due to severe gastrointestinal events and those associated with non-steroidal anti-inflammatory drug use. Am J Gastroenterol 2005, 100:1685-93.
4. Nielsen GL, Sorensen HT, Mellemkjoer L. Risk of hospitalization resulting from upper gastrointestinal bleeding among patients taking corticosteroids: a register-based cohort study. Am J Med 2001, 111:541-5.
5. Mittal R, Spero JA, Lewis JH. Patterns of gastrointestinal hemorrhage in hemophilia. Gastroenterology 1985, 88:515-22.
6. Lutcher CL. Hematologic problems in gastrointestinal bleeding. Gastrointestinal Bleeding 1992, 105-18. Sugawa CLucas CESchuman BM. In, eds, New York, Igaku-Shoin
7. Taylor DN, Blaser MJ. The epidemiology of Helicobacter pylori infection. Epidemiol Rev 1991, 13:42-59.
8. Braden B, Wenke A, Karich HJ. Risk of gastrointestinal bleeding associated with Helicobacter pylori infection in patients with hemophilia or von Willebrand's syndrome. Helicobacter 1998, 3:184-7.
9. Rattray B, Nugent DJ, Young G. Rofecoxib as adjunctive therapy for haemophilic arthropathy. Haemophilia 2005, 11:240-4.
10. FitzGerald GA, Patrono C. The coxibs, selective inhibitors of cyclooxygenase-2. N Engl J Med 2001, 345:433-42.
11. Rattray B, Nugent DJ, Young G. Celecoxib in the treatment of haemophilic synovitis, target joints, and pain in adults and children with haemophilia. Haemophilia 2006, 12:514-7.
12. Bombardier C, Laine L, Reicin A. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. N Engl J Med 2000, 343:1520-8. 2 p following 8
13. Silverstein FE, Graham DY, Senior JR. Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving non-steroidal anti-inflammatory drugs: a randomized, double-blind, placebo-controlled trial. Ann Intern Med 1995, 123:241-9.
14. Thalheimer U, Bosch J, Patch D, Burroughs A. Improved survival with non-selective beta blockers. Hepatology 2008, 48:2091-2.
15. Howden CW, Hunt RH. Guidelines for the management of Helicobacter pylori infection. Ad Hoc committee on practice parameters of the American college of gastroenterology. Am J Gastroenterol 1998, 93:2330-8.
16. D'Amico G, Pagliaro L, Bosch J. The treatment of portal hypertension: a meta-analytic review. Hepatology 1995, 22:332-54.
17. Schulman S, Rehnberg AS, Hein M, Hegedus O, Lindmarker P, Hellström PM. Helicobacter pylori causes gastrointestinal hemorrhage in patients with congenital bleeding disorders. Thromb Haemost 2003, 89:741-6.